Unravelling transthyretin cardiac amyloidosis: updates on diagnosis, treatment, and prevalence insights

Eur J Prev Cardiol. 2024 Aug 22;31(11):1418-1419. doi: 10.1093/eurjpc/zwae133.

Authors

Giandomenico Disabato^{1

2}, Andrea Attanasio¹, Gianluigi Guida¹, Massimo Piepoli^{1

3}

Affiliations

¹ Cardiology University Department, IRCCS Policlinico San Donato, Piazza Edmondo Malan, Milan 20097, Italy.
² Multimodality Cardiac Imaging Unit, IRCCS Policlinico San Donato, Via Morandi 30, Milan 20097, Italy.
³ Department of Preventive Cardiology, Wroclaw Medical University, Wroclaw, Poland.

PMID: 38593200
DOI: 10.1093/eurjpc/zwae133

No abstract available

Publication types

Editorial
Comment

MeSH terms

Amyloid Neuropathies, Familial* / diagnosis
Amyloid Neuropathies, Familial* / epidemiology
Amyloid Neuropathies, Familial* / therapy
Cardiomyopathies* / diagnosis
Cardiomyopathies* / epidemiology
Cardiomyopathies* / therapy
Genetic Predisposition to Disease
Humans
Mutation
Prealbumin / genetics
Prealbumin / metabolism
Prevalence

Substances

TTR protein, human
Prealbumin

Supplementary concepts

Amyloidosis, Hereditary, Transthyretin-Related